Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recent And Upcoming FDA Advisory Committee Meetings

Executive Summary

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered. 

You may also be interested in...



Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease

Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity. 

BMS’ Boerner Bets On AI-Driven R&D In India, Points To Potential For MS, Lupus Drugs

BMS CEO Boerner made predictions of AI being a game changer for R&D in India come true with plans to conduct AI-driven small molecule drug research in India, set to house the company’s largest R&D site outside of the US by next year. He also spoke of bringing its drugs to treat multiple sclerosis and Lupus to the country

German Row Over Classification Of Telemonitoring Software Looks Set To Rumble On

When does an app qualify as a medical device and when does it not? A German court case appears to have wider-reaching implications for medtech than might first appear.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS147487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel